Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues:      
Total revenues $ 186,419 $ 120,282 $ 251,453
Operating costs and expenses:      
Cost of Captisol 30,419 11,347 6,337
Amortization of intangibles 23,442 16,864 15,792
Research and development 59,392 55,908 27,863
General and administrative 64,435 41,884 37,734
Total operating costs and expenses 177,688 126,003 87,726
Income from operations 25,845 807,076 163,727
Other income (expense):      
Gain (loss) from short-term investments (16,933) 1,049 50,377
Interest income 8,078 28,430 13,999
Interest expense (27,420) (35,745) (48,276)
Other expense, net (108) (4,171) (6,497)
Total other income (expense), net (36,383) (10,437) 9,603
Income (loss) before income tax (10,538) 796,639 173,330
Income tax benefit (expense) 7,553 (167,337) (30,009)
Net income (loss) $ (2,985) $ 629,302 $ 143,321
Earnings Per Share [Abstract]      
Basic net income (loss) per share (USD per share) $ (0.18) $ 33.13 $ 6.77
Shares used in basic per share calculation (shares) 16,185 18,995 21,160
Diluted net income (loss) per share (USD per share) $ (0.18) $ 31.85 $ 5.96
Shares used in diluted per share calculation (shares) 16,185 19,757 24,067
Royalties      
Revenues:      
Total revenues $ 33,796 $ 46,976 $ 128,556
Captisol      
Revenues:      
Total revenues 109,959 31,489 29,123
Contract revenue      
Revenues:      
Total revenues 42,664 41,817 93,774
Vernalis      
Operating costs and expenses:      
Gain from sale of intangible assets 17,114 0 0
Promacta      
Operating costs and expenses:      
Gain from sale of intangible assets $ 0 $ 812,797 $ 0